Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

ClinicalTrials.gov ID: NCT04294004

Public ClinicalTrials.gov record NCT04294004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized and Non-randomized, Controlled, Single-blind and Open-label, Dose-finding, Multi-center, Parallel Group Study of Safety/Efficacy of KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of KUR-113 Bone Graft (TGplPTH1-34 in fibrin) compared to local autograft for the treatment of Degenerative Disk Disease (DDD).

Study identification

NCT ID
NCT04294004
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kuros Biosurgery AG
Industry
Enrollment
50 participants

Conditions and interventions

Interventions

Combination Product · Other

Eligibility (public fields only)

Age range
25 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2020 (Actual)
Primary completion
Jul 30, 2024 (Estimated)
Completion
Jul 30, 2025 (Estimated)
Last update posted
Aug 9, 2023

2020 – 2025

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of California San Diego La Jolla California 92093-0863 —
Justin Parker Neurological Institute Boulder Colorado 80303 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Northwestern University-Northwestern Memorial Hospital Chicago Illinois 60611 —
Indiana Spine Group Carmel Indiana 46032 —
Kansas Spine and Specialty Hospital Wichita Kansas 67226 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Orthopedic Associates of Michigan Grand Rapids Michigan 49525 —
Washington University in St. Louis St Louis Missouri 63110 —
Hospital for Special Surgery New York New York 10021 —
University at Buffalo Neurosurgery Williamsville New York 14221 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
South Texas Spine Center San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04294004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04294004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →